Propanc Biopharma, Inc. - PPCB

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$47K
QoQ value delta ($000)
-$20K (-29.85%)
Implied price effect (QoQ)
-80.45%
Shares
Total shares
462,396
QoQ shares delta
+333,505 (+258.75%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (PPCB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
UBS Group AG 19 182,614 0.0%
JANE STREET GROUP, LLC 15 143,212 0.0%
Marex Group plc 7 67,724 0.0%
Virtu Financial LLC 4 40,748 0.0%
Sassicaia Capital Advisers LLC 1 16,000 0.0%
XTX Topco Ltd 1 12,098 0.0%